Aigen Investment Management LP Boosts Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Aigen Investment Management LP lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 7.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,374 shares of the biotechnology company’s stock after acquiring an additional 97 shares during the quarter. Aigen Investment Management LP’s holdings in Axon Enterprise were worth $817,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $40,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $45,000. Prestige Wealth Management Group LLC increased its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the last quarter. Stonebridge Financial Group LLC purchased a new position in Axon Enterprise in the fourth quarter valued at $53,000. Finally, GPS Wealth Strategies Group LLC increased its holdings in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $499.31 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The company has a market capitalization of $38.07 billion, a price-to-earnings ratio of 129.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm has a 50-day simple moving average of $603.60 and a 200-day simple moving average of $527.57. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Wall Street Analysts Forecast Growth

Several research firms recently commented on AXON. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Barclays set a $726.00 target price on Axon Enterprise and gave the company an “overweight” rating in a report on Thursday, February 27th. Finally, Northland Securities raised their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,146 shares of company stock worth $3,262,847. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.